Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Vitiligo

Recruiting

Investigational

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational

Spain

Participants:0–17 years
Substances:Ruxolitinib

Contact Research Centre

Pyelonephritis acute

Recruiting

Registered drugNo placebo

Study on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Meropenem

Contact Research Centre

Chronic rhinosinusitis with nasal polyps

Recruiting

Registered drug

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Asthma

Recruiting

Registered drug

Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Neuroblastoma

Recruiting

Registered drugNo placebo

Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Irinotecan

Contact Research Centre

Ornithine transcarbamoylase deficiency

Recruiting

InvestigationalNo placebo

Long‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Adeno-Associated Virus Serotype Rh79 Containing The Human Otc Gene

Contact Research Centre

Duchenne muscular dystrophy+1

Recruiting

InvestigationalNo placebo

Long‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years

Contact Research Centre

Glomerulonephritis membranoproliferative+1

Recruiting

Registered drugNo placebo

Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pegcetacoplan

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Azacitidine

Contact Research Centre

Neoplasm

Recruiting

InvestigationalNo placebo

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Ifinatamab Deruxtecan

Contact Research Centre

Find therapies in clinical trials near you

329 trials match your criteria

Asthma

Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

Focal segmental glomerulosclerosis

A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

Vitiligo

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Pyelonephritis acute

Study on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections

Chronic rhinosinusitis with nasal polyps

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Asthma

Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

Neuroblastoma

Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma

Ornithine transcarbamoylase deficiency

Long‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A

Duchenne muscular dystrophy+1

Long‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy

Glomerulonephritis membranoproliferative+1

Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

Acute myeloid leukaemia

Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

Neoplasm

Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Patients Under 18 With Relapsed or Refractory Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.